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Abstract
Familial hemiplegic migraine is a rare autosomal domi-
nant disorder associated with stereotypic neurologic
aura phenomena including hemiparesis. So far two chro-
mosomal loci have been identified. Families linked to the
chromosome 19 locus display missense mutations with-
in the CACNL1A4 gene. Here we report on a family with
familial hemiplegic migraine and cerebellar ataxia with
recurrent episodes of acute paranoid psychosis with anx-
iety and visual hallucinations associated with migraine
attacks. Based on the clinical and haplotype evidence
indicating linkage to chromosome 19 in this family, we
hypothesize that a dysfunction of the mutated calcium
channel may be involved not only in the development of
hemiplegic migraine but also in the acute psychotic epi-
sodes observed in these patients.
Introduction
Familial hemiplegic migraine (FHM) is a rare autoso-
mal dominant disorder characterized by episodes with
severe pulsatile headache for a few hours or days with
concurrent hemiparesis or hemiplegia, and facultative
hemianopsia, blurring of vision, unilateral paresthesias,
or dysphasia [1]. Onset is usually between 5 and 30 years
with a predominance during youth [1]. Among the associ-
ated features reported are deafness, nystagmus, coma,
fever, meningism and confusion, which usually resolve
within a few hours, but may last days or even weeks [2, 3].
About 20% of the families display progressive cerebellar
atrophy with ataxia. All of the families with ataxia link to
chromosome 19p13 [4, 5]. This gene has recently been
identified and was shown to encode a brain-specific P/
Q-type Ca2+ channel ·1 subunit [6]. We describe 5 mem-
bers of a family with FHM and cerebellar ataxia, 2 of
which experienced recurrent episodes of true psychosis
accompanying the hemiplegic attacks.
Case Reports
The pedigree studied is a three-generation family with 3 members
affected with hemiplegic migraine associated with cerebellar ataxia,
and 2 additional members who only suffered from cerebellar ataxia
(fig. 1). All members of the family were investigated personally by the
authors, and informed consent was obtained. Their main clinical
data are summarized in table 1. All affected members suffered from
mild to moderate ataxia predominantly affecting speech and gait.
Unipedal hopping could not be performed. Additionally, there were
some intention tremor, nystagmus and saccadic eye movements. All
male members had episodes of hemiplegic migraine with a frequency
of about 2–3 attacks per year, which lasted from 3 days to 2 weeks.
Gender
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Fig. 1. Pedigree of the family.
They comprised severe unilateral throbbing headache, contralateral
hemiparesis and hemihypesthesia, as well as global aphasia in epi-
sodes with right-sided paresis, reduced consciousness, and an ele-
vated body temperature up to 40°C. In individual III:2, the attacks
were frequently triggered by mild head trauma.
In 2 patients (II:1 and II:3), the migrainous headache was fol-
lowed by an episode of paranoid psychosis within 24 h. Both patients
initially presented with acute panic attacks with anxiety, severe psy-
chomotor agitation, and a perplexed facial expression. Retrospec-
tively, the patients reported visual and auditory hallucinations. They
experienced formed colorful mobile persecutory visual hallucina-
tions, with perceptual distortions and illusions. Anxiety was caused
by persecutory delusions. There was no hyperventilation. Cognitive
examination during the attack showed complete disorientation in
time and place and severe impairment of recent memory. Their
mood was suspicious and their speech disjointed with paraphasia
and neologisms. On one occasion, patient II:3 was frightened by the
idea of being poisoned by the infusion he received which he saw dou-
bled and distorted. Later he reported that this had caused a kind of
anxiety he had not experienced before. These episodes lasted up to
2 weeks; treatment with haloperidol was effective in shortening the
episodes and relieving the symptoms. Magnetic resonance imaging
performed in patients II:1 and II:3 disclosed cerebellar atrophy but
no atrophy of the cortex. No vascular lesions were observed on T2-
weighted images. EEG during the attacks showed generalized theta-
delta dysrhythmias and focal slowing contralateral to the paresis
which resolved after the attack. During some of the attacks Doppler
ultrasound revealed an increased blood flow contralateral to the
hemiparesis. An angiography in the older brother was normal
and was performed without complication. Laboratory investiga-
Table 1. Clinical data of the family with FHM
Patient
I:1 II:1 II:2 II:3 III:2
f m f m m
Age at examination 84 46 42 42 12
Hemiplegic migraine – + – + +
Age of onset 20 17 8
Ataxia + + + + +
Psychosis – + – + –
MRI n.d. cerebellar
atrophy
n.d. cerebellar
atrophy
normal
n.d. = Not done.
tions including CSF analysis were completely normal, excluding any
signs of inflammation. The haplotypes in this family were gener-
ated by genotyping all available individuals with one intragenic
marker (D19S1150) and six markers flanking the CACNL1A4 gene
on chromosome 19p13 (D19S221, D19S226, D19S841, D19S411,
D19S410, D19S222). I:1 and II:3a refused blood drawing. As indi-
cated in figure 1 there was a common haplotype shared by all affected
individuals.
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Discussion
The family described here suffers from FHM, their
clinical course met the criteria of the International Head-
ache Society [7]. Approximately 50% of previously re-
ported families are linked to chromosome 19p13 and pre-
sumably all FHM families with cerebellar ataxia plus cer-
ebellar atrophy are linked to this locus [4, 5, 8]. Chromo-
some 19-linked cases of FHM are caused by missense
mutations within the CACNL1A4 gene which encodes a
brain-specific P/Q-type Ca2+-channel ·1 subunit [6]. It is
now well established that neurotransmitter release is de-
pendent on the entry of calcium into presynaptic nerve
terminals through voltage-sensitive ion-specific channels
[9]. Based on this theoretical evidence, acetazolamide has
been described to be effective in these channelopathies. In
our patients, long-term treatment with 125 mg acetaco-
lamide once daily seemed to reduce the frequency and
severeness of hemiplegic migraine attacks.
Recent investigations indicate that the 5-hydroxytryp-
tamine (5-HT) metabolism is under control of Ca2+ chan-
nels. Blockade of P/Q-type, but not of L-type Ca2+ chan-
nels inhibited the release of serotonin from hippocampal
synaptosomes [10], hippocampal slices [11] and in vivo
[12]. Several lines of evidence suggest that the serotoner-
gic system may be involved in the pathogenesis of mi-
graine [13]. In particular, drugs which interact with 5-HT
receptor subtypes appear to be effective in acute and long-
term treatment of migraine. Following the discovery of
the CACNL1A4 gene it was proposed that dysfunction of
human P/Q-type Ca2+ channels may result in an inappro-
priate control of serotonin release or postsynaptic hyper-
sensitivity to 5-HT, thus predisposing patients for mi-
graine attacks or impairing their self-aborting mecha-
nism.
Since a dysfunction in serotonergic metabolism is also
discussed as being involved in the physiopathology of
schizophrenia [14, 15], it may be hypothesized that a dis-
turbed 5-HT metabolism, caused by a genetically deter-
mined dysfunction of P/Q-type Ca2+ channels, may be the
pharmacological basis for psychotic episodes in some
migraine individuals, which have previously been de-
scribed in patients with FHM [16, 17]. A more detailed
understanding of the mechanisms leading to psychotic
episodes in FHM might open new insight into the patho-
physiology of psychosis.
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